← Back to knowledge base

Section 280E: Cannabis Federal Tax Treatment

Legal disclaimer: This reference summarizes how Section 280E and related tax law apply to cannabis businesses as of April 2026. It is not legal or tax advice. Cannabis tax strategy must be executed with a cannabis-specialized CPA and, where entity structuring is involved, a cannabis tax attorney. Case law citations and IRC references are provided for discussion purposes only.

Section 280E: Cannabis Federal Tax Treatment

Content date: 2026-04. 280E case law, Schedule III rescheduling status, and SAFE Banking legislative pipeline shift on a quarterly cadence. Verify current status before making capital-allocation or entity-structure decisions.

Summary

  • Section 280E of the Internal Revenue Code disallows ordinary and necessary business deductions for any trade or business that "consists of trafficking in controlled substances" listed in Schedule I or II of the Controlled Substances Act. Cannabis is currently Schedule I. COGS is the only material federal deduction available to cannabis operators.
  • This file is the canonical home for Section 280E in the cannabis industry skill per the Phase 17 rebalance. Other files (pricing, supply-chain, inventory-planning, trends) brief-mention 280E and cross-link here to avoid drift.
  • For COGS allocation mechanics (producer vs reseller, IRC 471-11 walkthrough, defensible-vs-overreach categories), see accounting.md. For per-state cannabis tax rates, see legality.md or run python query.py state <ST>.
  • "Under Schedule III" — the coda at the bottom of this file covers what would change if rescheduling lands. Within the main body, current federal law is the primary story (as of 2026-04).
  • Reminder: Every material tax decision described below must be executed with a cannabis-specialized CPA, and entity-structure decisions additionally require a cannabis tax attorney. Nothing in this file is legal or tax advice.

Status Dashboard

All rows "as of 2026-04."

| Item | Status | Notes | |------|--------|-------| | Federal schedule | Schedule I (unchanged) | Trump Executive Order issued 2025-12-18 directing DOJ to move marijuana to Schedule III; rulemaking in progress. | | Schedule III timing | Uncertain | DEA confirmed January 2026 that full administrative rulemaking must complete. Industry consensus: "not before 2027; could slip on litigation or procedural delay." | | SAFE / SAFER Banking | Stalled in committee | SAFER Banking Act reintroduced 2026 with 14 Senate cosponsors (8 D / 6 R). Senate Banking Committee Chair historically opposed; 32 state AGs signed bipartisan letter in July 2025. Full detail: banking.md §SAFE / SAFER Banking Act. | | Tax Court cases to watch | None pending that reshape CHAMP / Olive / Harborside / Alterman holdings (as of 2026-04; verify on refresh) | Current Tax Court docket shows no new cannabis-specific opinions reshaping these holdings since 2020. | | Last updated | 2026-04 | Refresh quarterly; rescheduling timeline is the single highest-impact driver. |

Why a dashboard: 280E status is the single highest-variance input to cannabis unit economics. Pricing, banking, capital-structure, and M&A decisions all move on quarterly legislative/regulatory signals. The dashboard exists so Claude — and Chase — can see freshness at a glance.

What Section 280E Is

Section 280E was enacted in 1982 after a convicted cocaine dealer successfully deducted the ordinary business expenses of his trafficking business on his federal tax return. Congress, unwilling to subsidize drug trafficking with normal deductions, passed 280E to disallow deductions for any "trade or business" whose activities consist of trafficking in Schedule I or II substances. The statute was written for narcotics cases. It has applied to state-legal cannabis ever since cannabis retail began generating federal taxable income — because cannabis is on Schedule I, not because cannabis is specifically called out.

The consequence is that a cannabis operator generating $10M in revenue, with the same cost structure as a non-cannabis retailer, pays roughly twice the federal income tax. Only Cost of Goods Sold (COGS) is deductible. Rent, payroll (non-production), marketing, utilities, interest on operating debt, depreciation on non-production assets, legal fees, office supplies, and virtually every other line normally appearing below gross profit on a P&L — all non-deductible at the federal level for a plant-touching cannabis business.

Who it applies to: Any plant-touching trade or business at any tier of the cannabis supply chain — cultivators, processors/manufacturers, distributors, retailers. Ancillary businesses (software vendors, security services, real estate holding companies, management companies) are generally outside 280E's scope, which is the architectural reason management-company and holding-company structures exist in the industry (see §Entity Structuring below).

What survives: COGS. For producers (cultivators, manufacturers, processors), COGS is relatively broad under IRC 471-11 and can include direct materials, direct labor, and a meaningful share of indirect production costs. For resellers (pure retail dispensaries), COGS is narrow under IRC 471-3 and limited to purchase price plus freight-in. This producer-vs-reseller distinction is the single highest-leverage structural decision in cannabis tax planning and is the subject of accounting.md.

What dies: Rent (except portions legitimately allocable to production), marketing, non-production payroll, non-production utilities, interest on operating debt, general legal and professional fees, non-production depreciation, insurance (except production-related), repairs and maintenance (except production-related), admin, and almost every other below-gross-profit line.

The effective-tax-rate headline: A cannabis retailer running on a standard 45% COGS / 30% OpEx cost structure sees its federal effective rate roughly double (from ~21% at the C-corp rate to ~45-50% effective on book income). The $10M retailer worked example below walks the math step by step.

280E in One Paragraph

Section 280E of the Internal Revenue Code disallows all ordinary and necessary business deductions for any trade or business that traffics in Schedule I or II controlled substances; cannabis is on Schedule I, so any plant-touching cannabis business — cultivator, processor, distributor, retailer — is barred from deducting rent, payroll, marketing, utilities, interest, and most other operating expenses at the federal level. Cost of Goods Sold (COGS) is the only material deduction that survives, and even COGS is narrowed for retailers (IRC 471-3) relative to producers (IRC 471-11). The practical result is an effective federal tax rate roughly double what a non-cannabis retailer pays on the same book income, which is why 280E mitigation dominates cannabis tax planning.

Statutory Text in Plain English

The literal statutory language of 280E is one sentence: it denies a deduction or credit for any amount paid or incurred in carrying on a trade or business that consists of trafficking in Schedule I or II controlled substances. Two words do the work. "Trafficking" is interpreted broadly by the Tax Court to mean any commercial activity involving the listed substance — cultivation, manufacturing, distribution, retail sale. "Trade or business" is the unit of analysis; if a single legal entity runs more than one trade or business, only the trafficking one is disallowed (this is the CHAMP carve-out). There is one statutory exception: COGS. Because COGS is a reduction to gross income rather than a deduction from gross income, the Sixteenth Amendment's gross-income limitation prevents Congress from denying it. That constitutional mechanic is why COGS survives and everything else dies.

Who 280E Does Not Apply To

Not everyone in the cannabis economy is 280E-exposed. The line is drawn at "plant-touching":

  • Non-plant-touching software vendors (Treez, Dutchie, LeafLogix, Blaze POS; seed-to-sale software like Metrc; analytics tools) — outside 280E. They sell services to cannabis operators; they do not traffic.
  • Non-plant-touching management companies with genuine economic substance — outside 280E (subject to Harborside's substance test).
  • Non-plant-touching real estate owners (IIPR, Chicago Atlantic, independent landlords) — outside 280E. They rent real estate; they do not traffic.
  • Non-plant-touching brand IP holding companies — outside 280E when structured correctly with arm's-length licensing.
  • Hemp / CBD businesses operating within the 2018 Farm Bill threshold (< 0.3% delta-9 THC) — outside 280E. Hemp is federally legal; it is not a Schedule I controlled substance.
  • Testing labs — technically plant-touching in a physical sense, but the IRS has historically respected the separation where labs have independent licensing, third-party ownership, and their own regulatory framework. Modern cannabis testing labs generally operate as ancillary businesses.
  • Ancillary service providers (armored car services, legal services, specialty insurance, consulting) — outside 280E.

The architectural significance is that the entire ancillary cannabis economy — billions of dollars of software, real estate, brand IP, consulting, and financing — exists in a deductible-expense regime that plant-touching operators do not enjoy. This is the main reason capital gravitates toward ancillary businesses and the main reason operators build management-company or holding-company structures to shift deduction-disallowed expenses into deductible entities where the economics permit.

The 280E Cash-Flow Mechanic

280E is often described as a "tax problem," but the operating consequence is really a cash-flow problem. Because effective federal tax runs 45-50% of book income rather than 21%, cannabis operators generate dramatically less free cash flow per dollar of revenue than comparable non-cannabis businesses. This cascades through the entire capital structure:

  • Less internal capital for growth. A $10M retailer retains $1.3M after federal tax under 280E vs $1.9M without. That $600K delta is what would have funded new stores, inventory expansion, or technology investment. Across a 10-location MSO, $6M/year of growth capital evaporates.
  • Higher cost of external capital. Because cannabis operators cannot service as much debt per dollar of EBITDA, lenders price accordingly — AFC Gamma, Chicago Atlantic, Pelorus, and other cannabis-specialized lenders charge 9-15% interest (as of 2026-04) vs 5-8% for comparable non-cannabis borrowers.
  • Working-capital strain. Cannabis AP often runs tighter than non-cannabis retail because the federal tax bill consumes cash that would otherwise sit in working capital. See supply-chain.md §Payment Mechanics for the downstream wholesale negotiation dynamic.
  • Exit-valuation compression. EBITDA multiples for cannabis businesses (public-comparables as of 2026-04: 3-6x EBITDA) are roughly half what comparable non-cannabis retail/CPG businesses trade at. Some of that discount is regulatory risk and capital-markets access; a meaningful portion is the 280E drag on post-tax cash-flow-to-enterprise-value ratios.

For deeper capital-access mechanics (cannabis lenders, sale-leaseback structures, capital-markets reality), see banking.md §Capital Access.

Worked Example: $10M Retailer Effective Tax

Illustrative as of 2026-04. 45% COGS and 21% C-corp rate are 2026 illustrative assumptions; operators at different scales and category mixes see different math.

Scenario: Adult-use retail dispensary, single location, $10M gross revenue, C-corp taxpayer.

| Line item | Non-cannabis retailer | Cannabis retailer (280E) | |-----------|-----------------------|--------------------------| | Gross revenue | $10,000,000 | $10,000,000 | | COGS (45% of revenue) | ($4,500,000) | ($4,500,000) | | Gross profit | $5,500,000 | $5,500,000 | | Rent | ($600,000) | ($600,000) | | Payroll (non-COGS) | ($1,800,000) | ($1,800,000) | | Marketing | ($250,000) | ($250,000) | | Utilities, admin, other | ($400,000) | ($400,000) | | Total operating expenses | ($3,050,000) | ($3,050,000) | | Book pre-tax income | $2,450,000 | $2,450,000 |

Federal taxable income calculation:

| Step | Non-cannabis retailer | Cannabis retailer (280E) | |------|-----------------------|--------------------------| | Starts from gross profit | $5,500,000 | $5,500,000 | | Non-cannabis: all OpEx deductible | ($3,050,000) | 280E: NONE deductible | | Cannabis 280E OpEx deduction | n/a | $0 | | Federal taxable income | $2,450,000 | $5,500,000 | | Federal tax @ 21% C-corp rate | $514,500 | $1,155,000 | | Retained after federal tax | $1,935,500 | $1,295,000 |

Effective federal rate on book income: 21.0% (non-cannabis) vs 47.1% (cannabis). Same book P&L, same economic activity, roughly 2.25x the federal tax bill.

Key insight: That $640,500 difference is pure retained-earnings destruction per year on a single $10M retailer. Stacked across a multi-location MSO, it is the single largest variable on a cannabis-industry balance sheet. Every conversation about cannabis capital structure — why valuations are depressed, why capital is scarce, why operators push so hard on wholesale price and payment terms — starts here.

Caveat: State cannabis excise and sales taxes are separate from this federal calculation. See §Total Effective Tax Burden below for stacked state + federal analysis.

Sensitivity: How the Effective Rate Moves with COGS %

The $10M example assumes a 45% COGS ratio — roughly the middle of the dispensary benchmark. Effective rate moves with COGS share because COGS is the only surviving deduction. The more of your cost structure sits above the gross-profit line (i.e., in COGS), the lower your effective 280E rate.

| COGS ratio | Federal taxable income on $10M | Federal tax @ 21% | Effective rate on $2.45M book income | Implication | |------------|-------------------------------|-------------------|--------------------------------------|-------------| | 35% COGS (premium / boutique dispensary) | $6,500,000 | $1,365,000 | 55.7% | Highest 280E drag; premium operators need highest pricing power to compensate | | 45% COGS (mid-market illustrative) | $5,500,000 | $1,155,000 | 47.1% | Baseline example above | | 55% COGS (value / volume dispensary) | $4,500,000 | $945,000 | 38.6% | Lower 280E drag; why value-tier dispensaries can survive on thinner margins | | 65% COGS (vertically integrated; much of "OpEx" capitalized) | $3,500,000 | $735,000 | 30.0% | Approaches normal tax — but requires IRC 471-11 producer status |

Key insight. A vertically integrated operator who can legitimately capitalize production costs under IRC 471-11 (see accounting.md) moves down this table. A pure retailer stuck with IRC 471-3 is pinned to the top of the table. This is the single largest economic driver behind vertical integration in cannabis — not channel capture, not brand control, but federal tax arbitrage.

Sensitivity: How the Effective Rate Moves with OpEx Composition

Within the non-COGS spend bucket, there is a subtle lever: some "OpEx" line items are truly OpEx (marketing, admin, rent for office space) while others are production-adjacent and could plausibly be re-classified to COGS for a producer (cultivation supervision, production-area utilities, production-area rent). Moving $500K from deduction-disallowed OpEx to 471-11 allocable COGS on a $10M producer saves approximately $105K in federal tax at 21% — a meaningful swing on what looks like a bookkeeping decision.

This is the mechanic that accounting.md §IRC 471-11 Walkthrough operationalizes. It is also the mechanic that Harborside polices — cross-entity cost shifts without economic substance are rejected.

Total Effective Tax Burden

Federal 280E does not stand alone. It stacks on top of state cannabis excise taxes, state sales taxes, and local option taxes that are themselves often specific to cannabis and not offsettable against the federal bite. The result is that the total effective tax burden on a cannabis retailer — federal + state + local — often reaches 35-55% of gross receipts in the highest-tax states, before operating costs are paid.

Illustrative as of 2026-04. Tax rates change quarterly in many states; the table below is for stacking-illustration only. For authoritative per-state rates, see legality.md or run python query.py state <ST>.

| State | Federal 280E adder (illustrative) | State cannabis excise | State sales | Local option | Combined effective rate on gross receipts (illustrative) | |-------|-----------------------------------|------------------------|-------------|---------------|----------------------------------------------------------| | California (CA) | ~6-8% of gross receipts equivalent | 15% state excise | 7.25-10.75% sales | Up to 10-15% local | ~40-50% combined | | Illinois (IL) | ~6-8% of gross receipts equivalent | 10-25% cannabis excise (potency-tiered) | 6.25% sales | ~3% local | ~30-45% combined | | New York (NY) | ~6-8% of gross receipts equivalent | 13% state + potency tax | 4% state sales + local | Up to 4.875% local | ~30-40% combined | | Michigan (MI) | ~6-8% of gross receipts equivalent | 10% adult-use excise | 6% sales | Municipal fees vary | ~25-30% combined |

How to read this table. The "Federal 280E adder" column converts the ~2.25x federal burden from the $10M retailer example into a gross-receipts-equivalent range (operators' actual federal adder depends on their COGS share and cost structure). The state columns are per-state cannabis-specific tax headlines — they do not include traditional state corporate income tax, which also applies. The "Combined" column is a rough arithmetic stack showing why operators in high-tax states frequently run 10-15% net margins on what looks like a 45-55% gross margin business.

Phase-4 deferral. Phase 4 (Legality & Compliance) stays canonical for per-state rate detail — structure, tiers, local option, medical vs adult-use splits, and the 50-state table. This §Total Effective Tax Burden section is an illustration of the stacking mechanic. If you are modeling a specific state's after-tax cash flow, read legality.md or query the database directly.

Why State Rates Do Not Offset Federal 280E

A common misconception is that high state cannabis taxes in some way "offset" the federal 280E burden, as if the total tax budget is fixed. The opposite is true. State cannabis excise and local option taxes are either pass-through to the consumer (collected and remitted, not a P&L hit) or separate line-items that reduce operator net income before the federal 280E calculation. Federal 280E then applies on top. The two burdens compound; they do not substitute.

Example: a CA retailer collects and remits 15% state excise plus ~10% combined state and local sales tax on every transaction. These show up as pass-through collections. The retailer then pays federal tax at the 280E-adjusted effective rate (~47% on book income) on whatever net income survives. Operators in low-state-tax states like Michigan retain more of the top line; operators in high-state-tax states like California see a smaller slice of revenue reach the bottom before federal 280E is applied.

Non-Cannabis State Income Tax

State income tax (on corporate profits or pass-through K-1 income) applies separately on top of the cannabis-specific excise taxes. Some states (CA, NY, IL) have codified that they follow the federal 280E disallowance for state income tax purposes — meaning the operator's state taxable income is computed off the 280E-expanded federal base. Others (OR, CO) have decoupled and allow state-level deduction of ordinary business expenses, producing a narrower state tax. This is a state-by-state detail that sits with legality.md; flagging here so operators know to ask their state-specific question.

Case Law Holdings

All four case summaries below are reproduced from the verified Phase 17 research as of 2026-04. Do not paraphrase into new claims. If a more recent precedent-setting case emerges, research update required. Current verified docket (as of 2026-04) shows no new Tax Court cannabis opinions reshaping these holdings since 2020.

CHAMP v. Commissioner (2007) — Dual Trade or Business

Californians Helping to Alleviate Medical Problems, Inc. v. Commissioner, 128 T.C. 173 (2007). CHAMP was a California medical-marijuana caregiver that also provided significant non-cannabis caregiving services (counseling, support groups, food, hygiene). The Tax Court held that CHAMP operated two distinct trades or businesses — the cannabis sale activity (subject to 280E) and the caregiving activity (not subject to 280E) — and that ordinary and necessary expenses of the non-cannabis trade or business were deductible even though the cannabis trade or business's expenses were disallowed. CHAMP is the foundational case allowing a "separate trade or business" deduction strategy, and remains the precedent every operator cites when attempting to segregate non-plant-touching activity from plant-touching activity for 280E purposes. Subsequent cases (Harborside, Alterman) have narrowed this doctrine substantially.

Olive v. Commissioner (2015) — Narrowing the Separate-Business Doctrine

Olive v. Commissioner, 139 T.C. 19 (2012), affirmed 792 F.3d 1146 (9th Cir. 2015). The Vapor Room Herbal Center in San Francisco operated a medical-cannabis dispensary alongside yoga and other "free" services. The Tax Court, affirmed by the Ninth Circuit, held that the non-cannabis activities did not constitute a separate trade or business because (a) they were provided free of charge and (b) they were economically intertwined with cannabis sales. Olive materially narrowed CHAMP: a "separate trade or business" must have its own independent economic substance and its own revenue stream. Free or merely ancillary activities do not clear the bar.

Patients Mutual Assistance Collective Corp. (Harborside) v. Commissioner (2018) — 99.5% Test and 263A Rule

Patients Mutual Assistance Collective Corp. d.b.a. Harborside Health Center v. Commissioner, 151 T.C. No. 11 (2018). The Tax Court held (a) Harborside had a single trade or business — cannabis sales generated over 99.5% of revenue, so non-cannabis activity did not qualify as a separate trade under CHAMP; and (b) IRC Section 263A (uniform capitalization) does not apply to cannabis resellers because 280E disallows what 263A would otherwise capitalize, meaning retailers cannot use 263A to broaden their COGS beyond the narrow 471-3 categories. Harborside is the controlling precedent that pure cannabis retailers have extremely limited COGS allocation flexibility — they are effectively stuck with purchase-price-plus-freight inventory cost and cannot capitalize store-level operating expenses into COGS.

Alterman v. Commissioner (2018) — Documentation Burden and "Completing the Sale"

Alterman v. Commissioner, T.C. Memo. 2018-83. Altermeds LLC, a Colorado dispensary, argued that sales of pipes, papers, and other non-cannabis accessories constituted a separate trade or business deductible under CHAMP. The Tax Court rejected this, holding that accessory sales "completed" the cannabis sale rather than constituting a genuinely separate business line (cannabis revenue dominated the P&L). Alterman is equally important for its documentation holding: the court disallowed numerous COGS deductions that Altermeds could not substantiate with adequate contemporaneous records. Alterman establishes that the documentation burden in cannabis is higher than in traditional retail — contemporaneous records tying every cost allocation to a defensible base (sqft, time tracking, meter readings) are required, not aspirational reconstructions.

Planner note: If a more recent precedent-setting case emerges, research update required. Current verified docket (as of 2026-04) shows no new Tax Court cannabis opinions reshaping these holdings since 2020.

What the four cases collectively say. CHAMP opened the door to separating non-cannabis trade-or-business activity for deduction purposes. Olive and Harborside closed most of that door — economic substance, independent revenue, and a non-trivial share of total activity are now required. Alterman set the documentation floor: even for legitimate COGS, the operator bears the burden of proving allocation bases contemporaneously. Together these holdings define the operating envelope every cannabis CPA and tax attorney works inside. A fifth major precedent-setting case would change the playing field; absent one, this is the constitution of cannabis tax planning.

How to Read the Case Law When Evaluating a Strategy

When an operator, CPA, or consultant proposes a 280E strategy, the four-case framework is the filter:

  1. Is there a credible separate trade or business? (CHAMP) — If the non-cannabis activity has its own customers, its own revenue line, its own staff, its own economic rationale independent of the cannabis operation, CHAMP supports carving it out.
  2. Does it have economic substance, not just form? (Olive) — Free services, artificially-priced "ancillary" activities, and thin-revenue sidelines fail. The activity must stand on its own economically.
  3. Does the non-cannabis activity represent a meaningful share of total revenue? (Harborside 99.5%) — If cannabis is more than ~95% of consolidated revenue, the separate-trade argument is fragile. Harborside's 99.5% threshold is not a safe harbor at exactly 99.5%; operators should want the non-cannabis share materially higher than single digits to argue credibly.
  4. Is the supporting documentation contemporaneous? (Alterman) — Contracts dated when executed, allocation methods documented in the period they applied, time-tracking data captured in the period worked. Retrospective reconstruction loses.

Any strategy that fails any one of these filters is audit-risk surface. A strategy that passes all four is still not safe without CPA and tax-attorney sign-off, but at least the analytic frame is correct.

Other Cases Sometimes Cited

Operators will occasionally encounter references to other cannabis tax opinions — Canna Care v. Commissioner, N. Cal. Small Bus. Assistants v. Commissioner (constitutional challenge to 280E), Feinberg v. Commissioner, and various informal memoranda. These cases largely reinforce rather than reshape the CHAMP / Olive / Harborside / Alterman framework. In particular, N. Cal. Small Bus. Assistants rejected the constitutional argument that 280E is an unconstitutional penalty, settling the fundamental validity of the statute for the foreseeable future. Unless a new precedent-setting opinion emerges, the four cases above remain the load-bearing authorities.

Status check reminder: The Status Dashboard above flags whether any new cases have emerged since the last refresh. Re-verify quarterly.

Deduction Strategy & COGS Positioning

Under 280E, COGS is the entire federal deduction story. Three posture categories structure the planning conversation:

  • Clearly deductible — direct COGS. Direct materials (seeds, clones, nutrients, packaging) for producers. Purchase price plus freight-in for resellers. No 280E risk; standard tax-accounting treatment.
  • Defensible with documentation — indirect production costs for producers (IRC 471-11). Production-area rent, metered production utilities, production supervision, quality testing, equipment depreciation allocable to production, production-related maintenance and insurance. Requires allocation-base documentation (sqft %, time-tracking, meter readings). Audit-survivable when documented; indefensible when reconstructed retrospectively.
  • Aggressive / risky — broad rent or labor allocation for pure retailers; cross-entity cost shifts without substance. Pure retailer attempts to capitalize store rent, sales labor, or marketing into COGS fail under 263A (Harborside). Related-party real-estate or management companies without economic substance fail under Harborside's successor-doctrine analysis. These are the positions that lose in Tax Court.

For IRC 471-11 mechanics, producer-vs-reseller distinctions, allocation-method decision tables, and the worked producer allocation example ($800K direct + $1.2M direct labor + $1,615K 471-11 indirect = $3,615K total COGS vs $2,000K naive), see accounting.md. This file is the canonical home for "what is 280E"; accounting.md is the canonical home for "how to account under 280E." Do not re-expand COGS mechanics here.

Entity Structuring

Cannabis entity-structure decisions are driven more by 280E than by any other single factor. The five archetypes below are operator-recognizable options. Each has pros, cons, and a best-for profile. None is a one-size-fits-all recommendation — entity structure interacts with state licensing rules, investor preferences, growth stage, and exit strategy.

| Structure | Pros | Cons | Best for | |-----------|------|------|----------| | C-corp (plant-touching) | MSO-standard; limits 280E to one entity; clean investor exit; traditional public-market structure | Double taxation on dividends; complex setup; state-level variation | Growth-stage plant-touching operators; MSOs; operators planning an IPO or strategic sale | | LLC (plant-touching) | Pass-through avoids corporate-level double tax; simpler governance; flexible profit/loss allocation | 280E hits the members personally (K-1 income); harder institutional-investor exit; state variation | Single-operator founder-led dispensaries; small multi-store independents where the owner intends to hold long-term | | S-corp (plant-touching) | Pass-through; payroll-vs-distribution flexibility can reduce self-employment tax | Ownership restrictions (100-shareholder cap, US-resident-only); state variation; 280E still hits shareholders; less flexible than LLC on allocations | Smaller established operators with stable ownership; owners who want W-2 + distribution mix | | Management company (non-plant-touching) | Rent, management fees, and service fees paid from plant-touching entity may be 280E-limited at the plant-touching side, but the management co itself is not 280E-exposed; isolates admin overhead in a deductible entity | Must be a bona-fide separate business with independent economic substance (Harborside / Olive risk); IRS scrutiny; inter-company pricing must be arm's length | Mature multi-location operators with scaled admin functions (HR, finance, marketing ops) that can credibly stand alone | | Holding company / tiered structure | Separates brands / IP / real estate from plant-touching operations; enables cleaner M&A; isolates asset-risk | Complex; requires tax-attorney design; inter-company pricing risk; state-licensing complications | MSOs; capital-raising operators; operators with significant IP / brand / real-estate value to protect |

Consult a cannabis tax attorney before implementing any of these structures. Harborside narrowed the separate-trade-or-business doctrine; aggressive structures without economic substance are rejected in audit. The difference between a well-designed management-company structure and a challengeable one is not the diagram on the whiteboard — it is whether the management entity has its own employees, its own service agreements, its own arm's-length pricing, and its own independent revenue. Paper separation without operational separation loses.

Common archetypes in practice:

  • MSO C-corp parent with state-LLC subsidiaries. Most publicly traded cannabis companies (Curaleaf, Trulieve, Green Thumb, Verano) use a parent C-corp with plant-touching LLC subsidiaries per state. 280E hits each plant-touching subsidiary; parent captures non-plant-touching overhead.
  • Owner-operator LLC with separate real-estate LLC. Single-location or small-chain operators often hold real estate in a separate, non-plant-touching LLC that leases to the dispensary at arm's-length rent. The real-estate LLC is outside 280E; the lease payment is non-deductible at the dispensary side but the dollars still flow to the owner via the real-estate entity.
  • Brand-licensing holding company. Brands (Stiiizy, Wyld, Cookies) often separate IP / brand licensing into a non-plant-touching holding company that licenses trademarks and know-how to plant-touching manufacturing partners. License fees are 280E-disallowed at the manufacturer side but flow to the holding company as ordinary deductible revenue.

Decision Frameworks

Is Your COGS Allocation Defensible? Checklist

Run this list quarterly. Each item is yes/no; any "no" is audit-risk surface that needs remediation.

  • [ ] Do you have contemporaneous documentation (dated the period it was incurred, not reconstructed) for every indirect cost allocated to COGS?
  • [ ] Is every allocation base (sqft %, time-tracking, meter reading, utilization) documented with an independent source (floor plan, time sheets, utility sub-meter data)?
  • [ ] Are production vs non-production spaces physically delineated in the facility, with sqft measurements matching the allocation?
  • [ ] Are production vs non-production labor hours time-tracked by batch or by task?
  • [ ] Are utilities either sub-metered by production area or allocated using a documented sqft method?
  • [ ] Have you consistently applied the same allocation method across periods (or documented the reason for any change in method)?
  • [ ] Is your producer/reseller classification correct — are you using IRC 471-11 only if you genuinely produce, and IRC 471-3 if you purely resell?
  • [ ] Does your monthly close include a 280E-allocation posting step, not a year-end reconstruction?

If more than two items are "no," the allocation is not audit-defensible. Before filing, get a cannabis CPA sign-off.

Should You Restructure as a Management-Co? Decision Tree

This is a decision tree, not a recommendation. Management-company structures carry real Harborside risk; the goal is to determine whether your situation crosses the threshold where the structure becomes worth designing.

  1. Do you operate 3+ plant-touching locations or entities?
    • No → Management-co overhead rarely pays off at this scale. Stop here; use single-entity structure.
    • Yes → Continue.
  2. Do you have scaled admin functions (HR, finance, marketing ops, IT) that could plausibly stand alone as a services business?
    • No → Paper-only management co will fail Harborside. Stop.
    • Yes → Continue.
  3. Can the management company plausibly have its own employees, its own service agreements with third parties, and its own independent revenue (not just inter-company transfers)?
    • No → Not a bona-fide separate business. Stop.
    • Yes → Continue.
  4. Do you have the budget for a cannabis tax attorney to design the inter-company pricing and service agreements, and for annual documentation maintenance?
    • No → The cost of challenge exceeds the savings. Stop.
    • Yes → Proceed with design — with a cannabis tax attorney, not DIY.

Operators commonly cross the threshold at ~$30M+ consolidated revenue or 5+ locations. Below that, the structure costs more than it saves.

280E Audit-Survival Documentation Checklist

What you need to produce in an audit, every month, without asking:

  • [ ] P&L by plant-touching entity, reconciled to the GL
  • [ ] COGS roll-forward with opening inventory, purchases (or production costs), and closing inventory
  • [ ] Metrc (or BioTrack / Leaf) seed-to-sale export tied to GL cost basis per batch
  • [ ] Floor plan with sqft measurements for production vs non-production areas
  • [ ] Sub-meter readings or documented sqft allocation method for utilities
  • [ ] Time-tracking data by batch / task for labor allocated to production
  • [ ] Signed inter-company service agreements (if management-co or holding-co structure)
  • [ ] Monthly allocation policy documentation (the method, the base, the documentation source)
  • [ ] Entity-structure diagram with arm's-length pricing for inter-company flows
  • [ ] Cannabis CPA engagement letter and annual review documentation

Retention: IRS recommends 7 years. For cannabis, keep indefinitely — audit cycles often reach back the full statutory window.

Common 280E Pitfalls

Pitfall 1: Allocating rent based on "gut feel" square footage

Operators eyeball their production vs retail sqft split and use a round number like "70/30" without a floor plan or measurement. This fails Alterman's documentation bar. The fix: Commission a professional floor plan with measured sqft by zone (grow rooms, trim, processing, office, retail, storage). Update when the facility changes. Use the measured numbers in every allocation. Keep the floor plan and the measurement methodology in the permanent tax file.

Pitfall 2: Deducting marketing spend because "it drove sales"

Marketing is a 280E-disallowed category. Operators sometimes argue that marketing spend should be capitalized into COGS because it drives product movement. This argument consistently loses — Harborside confirms that 280E disallows the category, and 263A does not rescue it. The fix: Accept marketing as non-deductible. Do not litigate it; do not attempt aggressive allocation. Budget for it as a post-tax expense and price products accordingly. Retailers often incorporate marketing into pricing strategy rather than attempting to deduct it.

Pitfall 3: Treating a related-party real estate entity as separate trade without economic substance

Operators set up a real-estate LLC that owns the dispensary building and "leases" to the plant-touching entity at above-market rent, hoping to shift deduction-disallowed rent out of the plant-touching entity's 280E exposure. Without arm's-length pricing and economic substance, this fails. The fix: Apply the Harborside test: does the real-estate LLC have its own financing, its own insurance, its own maintenance contracts, its own arm's-length lease terms (a market-rate appraisal)? If yes, the structure is defensible. If it's "us paying ourselves," it is paper-only and will be collapsed in audit.

Pitfall 4: Skipping Metrc-tied cost accounting → can't prove inventory cost basis

Operators run Metrc for compliance and QuickBooks for accounting, and never tie the two. At year-end they can't prove cost basis per batch, which defeats COGS deduction. The fix: Monthly Metrc→GL reconciliation. Every batch in Metrc has a cost basis in the GL. Inventory counts in Metrc reconcile to inventory value in the GL each month. A cannabis-specialized POS and accounting stack makes this mechanical; retrofitting 11 months later is usually impossible.

Pitfall 5: Commingling retail + wholesale P&L when retail hits 280E differently

Vertically integrated operators run retail (IRC 471-3, narrow COGS) and wholesale/production (IRC 471-11, broader COGS) in the same P&L and apply a blended allocation. This fails because the two tiers have different COGS rules. The fix: Segmented books per license tier. Separate chart-of-accounts hierarchy for retail vs production; separate allocation policies; separate COGS roll-forwards. Producer-tier cost items do not migrate into retail-tier COGS just because the same entity owns both.

Pitfall 6: Claiming 280E does not apply because "we're a small caregiver / medical collective"

280E applies to any trade or business "consisting of trafficking in controlled substances." Federal law does not recognize state-level medical exemptions for purposes of 280E. CHAMP-style separate-business carve-outs are narrow (Olive, Harborside). The fix: Assume 280E applies; plan for it; do not rely on medical-exception arguments that the Tax Court has consistently rejected. The CHAMP carve-out requires genuine separate-business substance with independent revenue — it is not available as a default "we help patients" claim.

Pitfall 7: Under-withholding on estimated quarterly payments

Operators project federal taxable income using book pre-tax income and set estimated payments accordingly. Under 280E, federal taxable income can be 2x book pre-tax income, so quarterly estimates are chronically under-paid. By Q4, the operator faces a large balance-due plus underpayment penalty. The fix: Project quarterly estimates off federal taxable income, not book pre-tax. Re-run the 280E add-back each quarter and true up. The underpayment penalty is a deadweight cost that careful quarterly estimation avoids entirely.

Pitfall 8: Filing amended returns for prior-year deductions post-rescheduling (before guidance)

When Schedule III rescheduling lands, some operators will be tempted to file amended returns for prior years, arguing that 280E was always constitutionally suspect or that the new schedule applies retroactively. Both arguments lose without Treasury / IRS transitional guidance permitting them. The fix: Wait for official IRS transitional guidance. Rescheduling is a prospective change in law; retroactive refund claims require statutory or administrative permission. Filing amended returns speculatively invites audit and penalty exposure with no rational upside.

Pitfall 9: Running plant-touching and non-plant-touching activity through a single bank account

Even when the legal entities are separate, operators sometimes commingle bank accounts for operational convenience. This destroys the audit defensibility of the separation. The fix: One bank account per legal entity. Inter-entity cash flows recorded as documented loans or service payments with written agreements. A mixed bank account signals to an auditor that the legal separation is paper-only.

Pitfall 10: Accepting a POS or accounting system that cannot tie to Metrc per batch

Many "general retail" POS and GL systems can roll up cannabis revenue adequately for sales reporting but cannot tie inventory cost to Metrc batch IDs — meaning at year-end, the COGS roll-forward cannot be reconstructed from source of truth. The fix: Vet the accounting stack against the Metrc reconciliation requirement at the time of implementation. Cannabis-specialized POS platforms (Treez, Dutchie, LeafLogix, Blaze) integrate natively; general-retail platforms often require expensive customization or manual workarounds. Cost of the right stack is dwarfed by cost of a failed audit.

Operator Scenarios

The frameworks above are abstract; the scenarios below illustrate how they apply in three common operator archetypes. All numbers are illustrative as of 2026-04.

Scenario A: Single-Location Independent Dispensary ($5M revenue)

A single-location adult-use dispensary in a mature market runs $5M revenue, 50% gross margin ($2.5M gross profit), and roughly $1.8M in OpEx (rent, payroll, marketing, utilities). Book pre-tax income is $700K.

Under 280E, federal taxable income is $2.5M (gross profit, no OpEx deducted). Federal tax at 21% C-corp rate is $525K — a 75% effective rate on book income. After state cannabis excise, state sales tax (pass-through to customer but operationally carried), and state income tax, the owner's take-home drops significantly.

Planning posture: No management-company overhead pays off at this scale. Standard LLC or S-corp structure (or single-member LLC filing as S-corp) is the baseline. The owner's leverage is (1) tight COGS discipline, including freight-in capitalization, (2) real estate held in a separate non-plant-touching LLC if owned, and (3) disciplined monthly Metrc reconciliation to survive audit. Rescheduling, if it lands, disproportionately benefits this archetype — the $525K federal bill drops toward ~$150K at 21% of book, a ~$375K annual swing.

Scenario B: Vertically Integrated Cultivator + Retailer ($25M revenue)

A vertically integrated operator runs a 20,000 sqft cultivation facility plus three retail locations. Consolidated revenue is $25M; cultivation contributes $10M (wholesale to own retail + some external), retail contributes $15M. Cultivation COGS under IRC 471-11 can include direct materials, direct labor, and allocated indirect production costs; retail COGS under IRC 471-3 is limited to wholesale transfer price plus freight.

The leverage point is the IRC 471-11 allocation. If the operator legitimately capitalizes $1.6M of production-facility rent, utilities, and supervision into cultivation COGS (following the allocation walkthrough in accounting.md), they recover roughly $336K in federal tax at 21% vs a naive direct-cost-only approach. The cultivation tier carries most of the post-tax margin; the retail tier, despite being larger by revenue, is pinned to the 471-3 narrow-COGS regime.

Planning posture: Segmented books per license tier (not commingled — see Pitfall 5). Documented allocation methodology with contemporaneous documentation. Potentially a management-company layer if the admin functions can stand alone (HR, accounting, marketing ops) — but only if the Harborside substance test is clearly met. Entity structure often a C-corp parent with LLC subsidiaries per license.

Scenario C: Multi-State Operator, 15 Stores, 3 States ($120M revenue)

An MSO running 15 stores across CA, IL, and NY, plus cultivation and manufacturing in each state. Consolidated revenue is $120M. Each state's plant-touching entities are separate LLCs filing as C-corps (or held by a C-corp holding). The parent is a Delaware C-corp.

At this scale, every lever matters. Management company for shared admin ($2M/year of HR, finance, marketing ops that can credibly stand alone): saves roughly $420K in federal tax if structured correctly. Holding-company IP licensing (proprietary strain genetics, brand names): shifts some deduction-disallowed royalty payments into a non-plant-touching entity. Real estate in separate entities per location. Cultivation tier maximizes 471-11 allocation.

Planning posture: Full cannabis tax-attorney design. Transfer-pricing studies for inter-company flows. Dedicated cannabis CPA, often internal controller plus Big Four consulting. Audit-defense playbook with contemporaneous documentation across all 15 locations. At this scale, 280E planning is a C-suite agenda item, not a CFO side project.

Common Thread Across Scenarios

The lever set is the same — COGS positioning, entity structure, documentation discipline — but the economics of each lever scale with operator size. Below ~$10M revenue, the tactical moves dominate (own your real estate in a separate LLC, capitalize freight-in, reconcile Metrc monthly). Above ~$30M, the structural moves become worth the design cost (management company, holding company, IP licensing). Above ~$100M, every lever is in play and 280E planning is institutional-grade.

Across all three scenarios, rescheduling is the single largest upside driver. The $5M operator saves ~$375K/year; the $25M operator saves ~$1.5M-2M/year; the MSO saves multiple $M/year per state. None of them should plan on it arriving before 2027.

Under Schedule III

If cannabis is rescheduled from Schedule I to Schedule III, Section 280E no longer applies — 280E is Schedule I / II specific. The practical effects would be large and immediate for most operators, though several transition questions remain open as of 2026-04.

What would change:

  • 280E exposure eliminated for most cannabis operators. Rent, payroll, marketing, utilities, and other ordinary business deductions become deductible at the federal level. Effective federal tax rate drops from the 45-50% book-income range to the 21% C-corp rate (or pass-through equivalent).
  • Estimated industry-wide tax savings: $268K-$800K per year per retailer depending on size (verified 2026-04, inherited from prior-phase trends.md analysis). For a $10M single-location retailer, roughly a $640K retained-earnings swing per year (from the worked example above).
  • COGS allocation pressure evaporates. Aggressive IRC 471-11 allocation becomes less consequential because ordinary OpEx is now deductible as-of-right. Producers' COGS advantage over retailers narrows substantially.
  • Capital structure shifts. Effective tax rate closer to normal CPG makes cannabis more investable for traditional institutional capital; valuations compress toward industry-comparable multiples.

What remains unchanged:

  • State cannabis-specific excise taxes. States that built cannabis tax regimes on top of adult-use legalization (CA, IL, NY, MI, and others) do not automatically repeal those on federal rescheduling. Total state + local cannabis tax burden persists — see §Total Effective Tax Burden above.
  • Local option taxes. Municipal add-ons, hosting fees, and public-benefit taxes remain state/local choices.
  • Banking access. Rescheduling reduces but does not eliminate banking hesitancy — see banking.md §Under Schedule III. SAFE / SAFER Banking remains a separate legislative path.

Transition mechanics — open questions:

  • Prior-year NOL treatment. Net operating losses accumulated under 280E were generated against a narrow deductible base. Whether they carry forward at full value post-rescheduling — or whether IRS transitional guidance constrains the carry-forward — is an open question. Operators with material NOLs should consult a cannabis CPA before modeling them.
  • Mid-year rescheduling. If the effective date falls mid-tax-year, allocation between pre- and post-rescheduling periods will require IRS guidance. Expect transitional rules similar to other Schedule changes.
  • Mid-cycle accounting-method changes. Shifts in inventory method or cost allocation driven by the 280E repeal may require IRS Form 3115 consents or automatic-change procedures.

Timing uncertainty. Industry consensus as of 2026-04 is "not before 2027; could slip further on litigation or procedural delay." Operators are planning as if 280E continues to apply through at least FY2027 and treating any earlier rescheduling as upside, not a plan-base assumption.

What happens to the deduction-planning ecosystem. A large part of the cannabis tax-advisory industry exists because of 280E. Cannabis-specialized CPAs, cannabis tax attorneys, COGS-maximization consultants, and entity-structuring advisors derive much of their value from navigating 280E. Rescheduling does not eliminate this profession — inventory accounting, multi-entity structuring, and multi-state tax planning remain complex — but the center of gravity shifts from "minimize 280E impact" to "optimize a normal corporate tax posture in a still-heavily-regulated industry." Operators should expect continued need for cannabis-specialized advisors post-rescheduling; the work content changes more than the demand.

What does not happen automatically. Rescheduling does not:

  • Legalize interstate commerce (that is a separate federal framework; state-level cannabis compliance still applies).
  • Open Visa / Mastercard cannabis transactions immediately (card-network authorization is a separate commercial decision by the networks — see payment-processing.md §Under Schedule III).
  • Eliminate Metrc / BioTrack / Leaf Data tracking-system obligations (state compliance persists).
  • Resolve state-federal conflict where state law prohibits cannabis (some states may maintain prohibitions even post-rescheduling).
  • Retroactively refund 280E taxes paid in prior years (barring specific IRS transitional guidance permitting this, which is not expected).

Planning trigger events to watch. The dashboard at the top of this file tracks these, but the near-term triggers operators should monitor are: DEA final rule publication; any federal court injunction or stay; executive-branch signals on timing; and IRS transitional guidance on NOL carry-forwards and Form 3115 consents. Any of these moves the timing needle materially.

The one-month-post-rescheduling checklist. If rescheduling lands, the operator's first-30-days playbook should include: (1) engage cannabis CPA to model prospective tax under the new schedule; (2) evaluate accounting-method changes and the Form 3115 requirements; (3) re-price OpEx that was optimized for 280E non-deductibility (marketing, store-level labor) against new deductibility; (4) re-evaluate entity structure — some 280E-driven structures become unnecessary overhead and should be collapsed; (5) model the year's quarterly estimated payments off the new schedule to avoid over- or under-withholding.

Appendix: Cross-Reference Index

  • accounting.md — IRC 471-11 walkthrough, producer-vs-reseller mechanics, inventory valuation, Cannabis Tax Calendar, defensible-vs-overreach categories
  • banking.md — why 280E cash-strips retailers and forces AP bottlenecks; SAFE / SAFER Banking canonical home; institutional landscape
  • payment-processing.md — transaction fees are non-deductible under 280E, which compounds the cost of expensive rails (cashless ATM 4% vs pinless debit 2%)
  • supply-chain.md §280E — wholesale-negotiation angle; why 280E shapes retailer margin expectations and payment-term pressure on wholesalers
  • pricing.md §280E Tax Impact — thin cross-reference to retail-pricing implications (thinned in the Phase 17 rebalance)
  • inventory-planning.md — year-end inventory tactical tip; cross-links back here
  • legality.md — authoritative per-state cannabis tax rates (CA, IL, NY, MI, and all regulated states)
  • glossary.md — terminology: 280E, COGS, plant-touching, total tax burden, EBITDA, margin

Phase 17 | FIN-01 | As of 2026-04